Evidence map›Paper›PMID 35142571›Full record

ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2022

Cortical lesion hotspots and association of subpial lesions with disability in multiple sclerosis.

Erin S Beck, Josefina Maranzano, Nicholas J Luciano, Prasanna Parvathaneni, Stefano Filippini, Mark Morrison, Daniel J Suto, Tianxia Wu, Peter van Gelderen, Jacco A de Zwart and 13 more

Open access · greenAbstract read
In one paragraph

Article in Multiple sclerosis (Houndmills, Basingstoke, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. medRxiv : the preprint server for health sciences · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Cortical Lesions Form Predominantly in Early Multiple Sclerosis.medRxiv : the preprint server for health sciences · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Article
  15. Article
  16. Article
  17. Imaging Outcomes for Phase 2 Trials Targeting Compartmentalized Inflammation.Multiple sclerosis (Houndmills, Basingstoke, England) · 2024
    Review
  18. Decoding Gray Matter Involvement in Multiple Sclerosis via Imaging.Neuroimaging clinics of North America · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 4 countries.

Erin S BeckNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-7839-7958
Josefina MaranzanoMcConnell Brain Imaging Centre, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada; Department of Anatomy, University of Quebec in Trois-Rivières, Trois-Rivières, QC, Canada.
Nicholas J LucianoNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Prasanna ParvathaneniNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Stefano FilippiniNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Mark MorrisonNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Daniel J SutoNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Tianxia WuNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Peter van GelderenNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Jacco A de ZwartNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-8155-8185
Samson AntelMcConnell Brain Imaging Centre, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
Dumitru FetcoMcConnell Brain Imaging Centre, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
Joan OhayonNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Frances AndradaNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Yair MinaNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Chevaz ThomasNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Steve JacobsonNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Jeff DuynNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Irene CorteseNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Sridar NarayananMcConnell Brain Imaging Centre, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
Govind NairNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Pascal SatiNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-6763-0125
Daniel S ReichNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-2628-4334
National Institutes of Health · USMontreal Neurological Institute and Hospital · CACedars-Sinai Medical Center · US

Funding

Multimodal MRI in Multiple SclerosisZIANS003119 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI REICH, DANIEL · 2010 to 2025
$53.4M
Magnetic Resonance Imaging Technology DevelopmentZIANS002990 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI DUYN, JEFF · 2009 to 2025
$25.5M
NINDS Quantitative MRI Core FacilityZICNS009438 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI NAIR, GOVIND · 2022 to 2025
$4.3M
Intramural NIH HHS Z99 NS999999Intramural NIH HHS ZIA NS003119
6 · The paper itself

Abstract

backgroundDramatic improvements in visualization of cortical (especially subpial) multiple sclerosis (MS) lesions allow assessment of impact on clinical course.

objectiveCharacterize cortical lesions by 7 tesla (T) T

methodsSixty-four adults with MS (45 relapsing-remitting/19 progressive) underwent 3 T brain/spine MRI, 7 T brain MRI, and clinical testing.

resultsCortical lesions were found in 94% (progressive: median 56/range 2-203; relapsing-remitting: 15/0-168;

conclusionCortical lesions are highly prevalent and are associated with disability and progressive disease. Subpial lesion burden is not strongly correlated with white matter lesions, suggesting differences in inflammation and repair mechanisms.

Indexed as

Multiple SclerosisPersons with DisabilitiesWhite MatterAdultBrainHumansMagnetic Resonance Imaging7 tesla MRIcortical lesionsMultiple sclerosis

Identifiers

PMID35142571
PMCPMC9256754
OpenAlexW4211236523

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.